Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.

Safety of insulin analogs during pregnancy: a meta-analysis

Lv, ShiShi, Wang, JiYing, Xu, Yong · 2015 · Archives of Gynecology and Obstetrics

Abstract

Objective The objective of this study was to assess the safety of four insulin analogs (aspart, lispro, glargine, and detemir) for the treatment of diabetes in pregnancy.Methods We searched Embase, Pubmed, and the Cochrane Central Register for Controlled Trials database through May 31, 2014. All articles were reviewed by two independent researchers, and if a discrepancy was noted, a third researcher was consulted. Results data were summarized by RevMan 5.2 software.Results Our search resulted in the retrieval and screening of 3519 studies. Of those, 24 studies met the eligibility criteria; the studies reported on a total of 3734 women with pre-gestational or gestational diabetes during pregnancy. The use of lispro was associated with lower rates of neonatal jaundice (RR = 0.63) and severe maternal hypoglycemia (RR = 0.33) than regular insulin. Lispro use was also associated with higher birth weight (WMD = 116.44) and an increased incidence of large for gestational age (LGA) births (RR = 1.42) compared with regular insulin. Rates of cesarean section and macrosomia were similar in pregnant women treated with aspart and regular insulin. Birth weights and rates of severe maternal hypoglycemia, respiratory dysfunction syndrome, and neonatal intensive care unit admission were similar after pregnant women were treated with glargine and NPH insulin. Rates of LGA, macrosomia, and neonatal hypoglycemia were similar after pregnant women were treated with detemir and NPH insulin.Conclusions Aspart, glargine, and detemir are safe treatment options for diabetes during pregnancy; these insulin analogs did not increase complications for the mothers or fetuses in our study. However, lispro was related to higher birth weight and increased rate of LGA in neonates. More high-quality randomized controlled trials are needed to clarify the best treatment options for diabetes during pregnancy.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00404-015-3692-3

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 40 references

Research works printed but not linked: 1

  1. Edson EJ, Bracco OL, Vambergue A et al (2010) Managing diabetes during pregnancy with insulin lispro :a safe alternative to human insulin. Endocr Pract 16:1020–1027 · DOI

Cited by

See all 100

Metadata

Authors
Lv, S., Wang, J., & Xu, Y.
Affiliations
Southwest Medical University (CN)
Corresponding author
Xu, Yong
Venue
Archives of Gynecology and Obstetrics
Published
2015-04-09
Volume
292
Issue
4
Pages
749-756
ISSN
  • 0003-9128 (ISSN-L)
  • 0932-0067
  • 1432-0711
OpenAlex
W2048000124
Cited by
88
References
40
Citations by year
2026: 3 · 2025: 1 · 2024: 2 · 2023: 19 · 2022: 7 · 2021: 8 · 2020: 6 · 2019: 15 · 2018: 12 · 2017: 3 · 2016: 9 · 2015: 3
FWCI
1.33
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Archives of Gynecology and Obstetrics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
insulin analogues, diabetes in pregnancy, gestational diabetes mellitus, pregestational diabetes, insulin aspart, insulin lispro, insulin glargine, insulin detemir, neonatal hypoglycemia, neonatal jaundice, birth weight, large for gestational age, macrosomia, cesarean section, neonatal intensive care admission, NPH insulin, regular insulin
MeSH terms
Insulin Glargine, Insulin Detemir, Adult, Birth Weight, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Infant, Newborn, Infant, Newborn, Diseases, Insulin, Pregnancy, Pregnancy in Diabetics, Pregnancy Outcome, Diabetes, Gestational, Insulin Aspart, Insulin Lispro

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Safety of insulin analogs during pregnancy: a meta-analysis. https://app.cochat.ai/papers/10.1007/s00404-015-3692-3
The paper
Lv, S., Wang, J., & Xu, Y. (2015). Safety of insulin analogs during pregnancy: a meta-analysis. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-015-3692-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.